CHICAGO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that its Board of Directors has declared a distribution of $0.18 per share for the fourth quarter of 2025, payable on December 31, 2025 to stockholders of record as of December 23, 2025. In October 2012, the Company adopted a dividend reinvestment plan that provides for reinvestment of distributions on behalf of its stockholders, unless a stockholder elects to receive cash prior to the record ...

DALLAS, Dec. 15, 2025 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NYSE: CSW) today announced its Board of Directors approved the expansion of its current share repurchase program authorization to $250 million, increasing the existing $200 million authorization. Since the commencement of CSW’s share repurchase program in 2017 and to date, the Company has repurchased approximately 2.3 million shares for a total of $251.6 million, at an average share price of $107.53. Under the current share repurchase program ...

The board of directors of Probe Gold Inc. unanimously recommends that shareholders vote FOR the proposed plan of arrangement.Your vote is important no matter how many votes you hold. Vote today.Shareholders who have questions or need assistance with voting their shares should contact Probe’s proxy solicitation agent and shareholder communications advisor Laurel Hill Advisory Group by telephone at 1-877-452-7184 or by email at assistance@laurelhill.com. TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Probe Gold I ...

Abivax Presents Third Quarter 2025 Financial Results Cash and cash equivalents of EUR 589.7 (as of September 30, 2025) with a cash runway into Q4 2027 PARIS, France, December 15, 2025, 10:05 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, announce ...

Findings provide scientific insights into the contributions of IDO1 and PD-L1 vaccination to PD-1 blockade for the treatment of metastatic melanomaFive-year analysis of median progression free survival was 25.5 monthsThese results reinforce the potential of immune-modulatory vaccination NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the publicatio ...

CONSHOHOCKEN, Pa., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the J.P. Morgan Annual Healthcare Conference on Monday, January 12, 2026 at 1:30pm PST. The presentation will be broadcast live and can be accessed here or by visiting Madrigal’s Investor Relations Events and Presentations page. A replay of the webcast will be available after the event. About MadrigalMadrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biophar ...

SANTA CLARA, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of differentiated data and analytics solutions for the semiconductor and electronics industries, today announced that long-time customer DENSO CORPORATION is highlighting how PDF’s Exensio® analytics software has contributed to the success of Denso’s 300mm IGBT manufacturing operations. DENSO is a global automotive parts manufacturer specializing in advanced automotive technologies, systems, and pro ...

Acquisition Accelerates BlackLine's Vision for an AI-Powered Finance and Accounting PlatformLOS ANGELES, Dec. 15, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), the future-ready platform for the Office of the CFO, today announced it has acquired WiseLayer, a New York-based company that has pioneered a digital workforce of AI-powered agents to automate complex, judgment-based finance and accounting processes. Terms of the deal were not disclosed. This acquisition takes BlackLine’s industry-leading au ...

- AEON and Daewoong Pharmaceutical have executed definitive documentation to exchange $15 million of notes plus accrued interest into new equity, $1.5 million of new notes due 2030, and a cash-exercise warrant for 8 million shares of common stock – - Exchange remains subject to shareholder approval - IRVINE, Calif., Dec. 15, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company seeking accelerated and full-label U.S. market entry by devel ...

ATHENS, Greece and NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Heidmar Maritime Holdings Corp. (the "Company" or "Heidmar") (NASDAQ: HMR) announced that the Company’s 2025 Annual Meeting of Shareholders (the “Meeting”) was duly held today in a virtual-only format pursuant to the Notice of Annual Meeting of Shareholders dated November 12, 2025. At the Meeting, shareholders approved and adopted the following proposal set forth in the Notice and the Company’s Proxy Statement: to elect two Class I Directors to ...